Lv6128
2530 积分 2024-04-25 加入
Assessment of the abuse of tapentadol immediate release: The first 24 months
22分钟前
求助中
Abuse of tapentadol compared to other atypical opioids among individuals entering treatment for opioid use disorders
2小时前
已关闭
Socioeconomic inequalities in cancer incidence and access to health services among children and adolescents in China: a cross-sectional study
4天前
已完结
Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats
5天前
已关闭
ACR Appropriateness Criteria® Imaging of Suspected Intracranial Hypotension
10天前
已完结
ICU Staffing in the United States
1个月前
已完结
Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy
1个月前
已完结
PAINWeek Abstract Book 2016
1个月前
已完结
Cancer‐related chronic pain: Investigation of the novel analgesic drug candidate cebranopadol in a randomized, double‐blind, noninferiority trial
1个月前
已完结
AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review
2个月前
已完结
皖公网安备34019202002308
